Education
About Us
Working with TipRanks
Follow Us
Merck & Company (MRK)
NYSE:MRK
MRK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$73.31 - $129.03
Previous CloseN/A
Volume3.30M
Average Volume (3M)16.48M
Market Cap
$209.32B
Enterprise Value$224.74B
Total Cash (Recent Filing)$9.23B
Total Debt (Recent Filing)$34.84B
Price to Earnings (P/E)12.1
Beta0.37
Next Earnings
Jul 29, 2025EPS Estimate
2.03Last Dividend Ex-Date
Jun 16, 2025Dividend Yield3.89%
Share Statistics
EPS (TTM)2.22
Shares Outstanding2,511,031,300
10 Day Avg. Volume13,085,408
30 Day Avg. Volume16,481,720
Financial Highlights & Ratios
PEG Ratio5.95
Price to Book (P/B)4.14
Price to Sales (P/S)0.00
P/FCF Ratio11.65
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue0.89
Enterprise Value/Gross Profit4.34
Enterprise Value/Ebitda2.38
Forecast
1Y Price Target
$103.80Price Target Upside24.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Merck & Company News
Bulls Say, Bears Say
Bulls Say
AcquisitionThe acquisition of Verona Pharma is seen as a strategic fit within MRK's cardiopulmonary franchise.
Growth PotentialThe stock is considered too cheap for the growth it should be able to deliver on both a near- and long-term basis.
Product PerformanceOhtuvayre, a product from Verona Pharma, has shown a strong trajectory since its launch, surpassing expectations.
Bears Say
Financial ImpactThe deal is expected to negatively impact non-GAAP EPS by ~$0.16 in the first 12 months.
International SalesContinued vaccine weakness is expected as Gardasil estimates may not fully account for China and Japan headwinds.
Market ConcernsA continued Gardasil overhang, pending Keytruda competitor datasets, and an out of favor sector may continue to make investors apprehensive.
Ownership Overview
0.05% Insiders
21.33% Mutual Funds
14.80% Other Institutional Investors
40.27% Public Companies and Individual Investors
MRK FAQ
What was Merck & Company’s price range in the past 12 months?
Merck & Company lowest stock price was $73.31 and its highest was $129.03 in the past 12 months.
What is Merck & Company’s market cap?
Merck & Company’s market cap is $209.32B.
When is Merck & Company’s upcoming earnings report date?
Merck & Company’s upcoming earnings report date is Jul 29, 2025 which is in 14 days.
How were Merck & Company’s earnings last quarter?
Merck & Company released its earnings results on Apr 24, 2025. The company reported $2.22 earnings per share for the quarter, beating the consensus estimate of $2.133 by $0.087.
Is Merck & Company overvalued?
According to Wall Street analysts Merck & Company’s price is currently Undervalued.
Does Merck & Company pay dividends?
Merck & Company pays a Quarterly dividend of $0.81 which represents an annual dividend yield of 3.89%. See more information on Merck & Company dividends here
What is Merck & Company’s EPS estimate?
Merck & Company’s EPS estimate is 2.03.
How many shares outstanding does Merck & Company have?
Merck & Company has 2,511,031,300 shares outstanding.
What happened to Merck & Company’s price movement after its last earnings report?
Merck & Company reported an EPS of $2.22 in its last earnings report, beating expectations of $2.133. Following the earnings report the stock price went up 1.398%.
Which hedge fund is a major shareholder of Merck & Company?
Currently, no hedge funds are holding shares in MRK
Merck & Company Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$103.80 (24.52% Upside)
$103.80 (24.52% Upside)
Blogger Sentiment
Bullish
MRK Sentiment 91%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 9.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $352.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.1%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.18%
12-Months-Change
Fundamentals
Return on Equity
39.31%
Trailing 12-Months
Asset Growth
8.76%
Trailing 12-Months
Company Description
Merck & Company
Merck & Company, Inc. (MRK), known as MSD outside the United States and Canada, is a global healthcare company that engages in the discovery, development, manufacturing, and marketing of a wide range of pharmaceutical products. The company operates in the healthcare sector, primarily focusing on prescription medicines, vaccines, biologic therapies, and animal health products. Merck's core product areas include oncology, vaccines, infectious diseases, and cardio-metabolic disorders, with a commitment to addressing unmet medical needs worldwide.
MRK Company Deck
MRK Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced view with strong emphasis on future growth potential through a robust pipeline and key product launches, while addressing challenges such as declining Gardasil sales in China and the impact of tariffs and foreign exchange. While there are significant growth drivers, the lowlights indicate notable challenges that could affect near-term performance.Read More>MRK Sales Breakdown
89.45% Pharmaceutical
9.16% Animal Health
1.39% Other
MRK Stock 12 Month Forecast
Average Price Target
$103.80
▲(24.52%Upside)